Results 11 to 20 of about 5,073 (155)

Surgical treatment for high-grade pseudomyxoma peritonei originated from appendix: Analysis of clinical outcomes of repeated debulking surgery [PDF]

open access: yesKorean Journal of Clinical Oncology, 2016
Purpose To evaluate the effect of repeated debulking surgery for high-grade pseudomyxoma peritonei (PMP) originating from the appendix. Methods Between January 1998 and December 2014, fifty patients, who underwent debulking surgery for high-grade PMP ...
Jung Hyun Park   +9 more
doaj   +1 more source

A 61-year-old woman with jejunal lymphatic malformation visualized on computed tomography: a case report

open access: yesJournal of Medical Case Reports, 2021
Background Jejunal lymphatic malformations are congenital lesions that are seldom diagnosed in adults and rarely seen on imaging. Case presentation A 61-year-old Caucasian woman was initially diagnosed and treated for mucinous ovarian carcinoma. After an
Mark Rupasinghe   +6 more
doaj   +1 more source

Secondary surgical cytoreduction needs to be assessed taking into account surgical technique, completeness of cytoreduction, and extent of disease

open access: yesWorld Journal of Surgical Oncology, 2020
Recent evidence suggested that secondary surgical cytoreduction followed by chemotherapy does not result in longer overall survival in patients with platinum-sensitive recurrent ovarian cancer.
Juan José Segura-Sampedro   +3 more
doaj   +1 more source

Morbidity and Mortality Rates Following Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy Compared With Other High-Risk Surgical Oncology Procedures [PDF]

open access: yesJAMA Network Open, 2019
Currently, rates of referral of patients with peritoneal metastasis in the United States who qualify for cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) are low, in part because of the misperception of high morbidity and mortality rates.
Foster, Jason M.   +7 more
openaire   +2 more sources

Survival Impact of Secondary Cytoreductive Surgery for Recurrent Ovarian Cancer in an Asian Population

open access: yesOman Medical Journal, 2015
Objective: The aim of this study was to evaluate the role of secondary cytoreductive surgery in Asian patients with recurrent ovarian cancer and to assess prognostic variables on overall post-recurrence survival time.
Rani Akhil Bhat   +5 more
doaj   +1 more source

A novel algorithm for the treatment strategy for advanced epithelial ovarian cancer: consecutive imaging, frailty assessment, and diagnostic laparoscopy

open access: yesBMC Cancer, 2017
Background This study aimed to evaluate the perioperative outcomes and prognostic impact of the consecutive steps of imaging, frailty assessment, and diagnostic laparoscopy (DLS) in patients with advanced epithelial ovarian cancer (EOC). Methods Patients
Kyung Jin Eoh   +6 more
doaj   +1 more source

Preliminary Experience and Morbidity Analysis of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS/Hipec) from a Tertiary Cancer Center in India [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2015
Background: Peritoneal carcinomatosis (PC) can arise directly from peritoneum (primary) or from regional spread of gastrointestinal and gynecological malignancies. It is often considered a terminal event.
Naveen Padmanabhan   +4 more
doaj   +1 more source

Trends in extent of surgical cytoreduction for patients with ovarian cancer.

open access: yesPLoS ONE, 2021
PurposeTo identify patient and hospital characteristics associated with extended surgical cytoreduction in the treatment of ovarian cancer.MethodsA retrospective analysis using the National Inpatient Sample (NIS) database identified women hospitalized ...
Deanna H Wong   +7 more
doaj   +3 more sources

Assessing morbidity, mortality, and survival in patients with peritoneal carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

open access: yesRevista do Colégio Brasileiro de Cirurgiões, 2023
Peritoneal carcinomatosis (PC) indicates advanced stage cancer, which is generally associated with a poor outcome and a 6 to 12 months. Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is an option for treating patients ...
JAIRO SEBASTIÁN ASTUDILLO VALLEJO   +7 more
doaj   +2 more sources

Guidelines from the Polish Surgical Society and Polish Society of Oncological Surgery Concerning Quality Assurance for Centres Performing Cytoreductive Procedures and HIPEC Procedures in the Treatment of Primary and Secondary Peritoneal Tumours

open access: yesNowotwory. Journal of Oncology, 2020
Surgical treatment of patients with peritoneal metastases in combination with Hyperthermic intraperitoneal Chemotherapy (HIPEC) and systemic treatments is applied with increasing frequency and, with correct patient qualification, allows for obtaining 5-year survival at a level of 32–52%.
Tomasz Jastrzębski   +20 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy